Pluto Biosciences, Inc

GSE145359: SIRT3, a therapeutic target in DLBCL

Bulk RNA sequencing

We report that in absence of ATM signaling SIRT3 stimluated pathways are critical for development of DLBCL SOURCE: Heather,Huot,Creasy Institute for Genome Sciences

View this experiment on Pluto Biosciences, Inc